Similar articles for PMID: 38991750

Year	Number of Results
2003	1
2004	2
2006	1
2007	2
2008	3
2009	2
2010	4
2011	3
2012	3
2013	6
2014	2
2015	11
2016	9
2017	10
2018	18
2019	20
2020	10
2021	11
2022	6
2023	4
2024	2

1

Diagnostic Performance of ¹⁸F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma.

Clement C, Leclère JC, Maheo C, Le Pennec R, Le Gal G, Delcroix O, Robin P, Rousset J, Tissot V, Gueguen A, Allio M, Bourbonne V, Schick U, Marianowski R, Salaun PY, Abgral R. Clement C, et al. J Nucl Med. 2024 Aug 1;65(8):1181-1187. doi: 10.2967/jnumed.124.267391. J Nucl Med. 2024. PMID: 38991750

2

Diagnostic Accuracy of ¹⁸F-FDG-PET/CT and ¹⁸F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI.

Murtojärvi S, Malaspina S, Kinnunen I, Tuokkola T, Honka MJ, Saunavaara V, Tolvanen T, Schrey A, Kemppainen J. Murtojärvi S, et al. Contrast Media Mol Imaging. 2022 Aug 24;2022:8676787. doi: 10.1155/2022/8676787. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 36082064 Free PMC article.

3

Use of Diffusion-Weighted Imaging and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Noij DP, Martens RM, Koopman T, Hoekstra OS, Comans EFI, Zwezerijnen B, de Bree R, de Graaf P, Castelijns JA. Noij DP, et al. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11. Clin Oncol (R Coll Radiol). 2018. PMID: 30318343

4

Clinical utility of ¹⁸F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.

Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY. Ha SC, et al. Acta Otolaryngol. 2019 Sep;139(9):810-815. doi: 10.1080/00016489.2019.1632483. Epub 2019 Jul 5. Acta Otolaryngol. 2019. PMID: 31274365

5

Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Martens RM, Noij DP, Koopman T, Zwezerijnen B, Heymans M, de Jong MC, Hoekstra OS, Vergeer MR, de Bree R, Leemans CR, de Graaf P, Boellaard R, Castelijns JA. Martens RM, et al. Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4. Eur J Radiol. 2019. PMID: 30927958

6

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY. Abgral R, et al. J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17. J Nucl Med. 2009. PMID: 19091901 Free article. Clinical Trial.

7

¹⁸F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.

Kim SA, Roh JL, Kim JS, Lee JH, Lee SH, Choi SH, Nam SY, Kim SY. Kim SA, et al. Eur J Cancer. 2017 Feb;72:62-70. doi: 10.1016/j.ejca.2016.11.009. Epub 2016 Dec 24. Eur J Cancer. 2017. PMID: 28027517

8

Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.

Robin P, Abgral R, Valette G, Le Roux PY, Keromnes N, Rousset J, Potard G, Palard X, Marianowski R, Salaun PY. Robin P, et al. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):72-8. doi: 10.1007/s00259-014-2889-1. Epub 2014 Aug 29. Eur J Nucl Med Mol Imaging. 2015. PMID: 25169701

9

FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.

Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K. Suenaga Y, et al. Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19. Eur Radiol. 2016. PMID: 26188656

10

¹⁸F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.

van den Bosch S, Doornaert PAH, Dijkema T, Zwijnenburg EM, Verhoef LCG, Hoeben BAW, Kasperts N, Smid EJ, Terhaard CHJ, Kaanders JHAM. van den Bosch S, et al. Radiother Oncol. 2020 Jan;142:107-114. doi: 10.1016/j.radonc.2019.07.025. Epub 2019 Aug 19. Radiother Oncol. 2020. PMID: 31439447 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year